Home » Archive

Articles Archive for February 2009

Research Commercialization »

[ 5 Feb 2009 | One Comment | 114 views]
ABC of Translational Research

What is it?
“Translational research transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical applications…” – definition from Translational Research Working Group (TRWG) .
Discoveries generally kick off as basic research on the “bench”, but it is important to translate these marvelous progresses to the patient’s “bedside”, on a clinical level. Thus, as rightfully [...]

IP and Regulatory Affairs »

[ 3 Feb 2009 | 2 Comments | 365 views]
HSA’s role in regulation of BMS in Singapore

When joining the Biomedical Sciences sector, it is essential to understand the industry itself. BMS is a dynamic and fast paced industry which is diverse in its political systems, culture and economic development. A strong and fast growing industry that has the capability of driving a country’s economy cannot be left unregulated. Regulations plays an [...]

Research Commercialization »

[ 3 Feb 2009 | No Comment | 58 views]
Hub of Translational Research

In the recent years, Asia has presented itself as a fresh, emerging player in the biomedical science industry. As a cosmopolitan city in Asia, Singapore is aiming to take her fair share in the limelight of this industry, particularly in the field of translational research.
Singapore is ambitious about carving out its niche in the field [...]

Medical Technology Manufacturing »

[ 3 Feb 2009 | 3 Comments | 1,231 views]
Medical Technology Manufacturing in Singapore

The Growth of the Medical Technology Manufacturing Industry in Singapore
The United Nations statistics on aging population predicts the number of people aged 60 and above to increase from 629 million to 2 billion by the year 2050. Such a trend sets a rising demand for better quality health care systems and solutions (EDB Singapore, 2009). [...]

Pharmaceutical Manufacturing »

[ 3 Feb 2009 | 2 Comments | 1,032 views]
Good news from GSK, but is it enough?

US pharmaceutical giant GlaxoSmithKline (GSK) brings good news to Singapore, beyond the Ribena and Panadol (yes, they are the ones bringing you your familiar consumer health care products, vaccines and prescription medicine).
On 26 January 2008, during Prime Minister Lee Hsien Loong’s visit to its Jurong plant, GSK announced that it will invest another $100 million [...]